Steven Cohen’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.6M | Sell |
106,157
-177,680
| -63% | -$26.6M | 0.02% | 986 |
|
|
2026
Q1 | $43.4M | Buy |
+283,837
| New | +$43.5M | 0.06% | 432 |
|
|
2025
Q3 | – | Sell |
-746,706
| Closed | -$91.1M | – | 2570 |
|
|
2025
Q2 | $90.4M | Sell |
746,706
-335,669
| -31% | -$37.8M | 0.18% | 134 |
|
|
2025
Q1 | $121M | Buy |
+1,082,375
| New | +$115M | 0.28% | 78 |
|
|
2023
Q4 | – | Sell |
-181,247
| Closed | -$17.5M | – | 2614 |
|
|
2023
Q3 | $18.5M | Sell |
181,247
-725,039
| -80% | -$73.6M | 0.05% | 427 |
|
|
2023
Q2 | $91.5M | Sell |
906,286
-905,061
| -50% | -$90.5M | 0.27% | 85 |
|
|
2023
Q1 | $167M | Buy |
1,811,347
+1,105,547
| +157% | +$96.6M | 0.52% | 27 |
|
|
2022
Q4 | $64M | Buy |
705,800
+56,100
| +9% | +$4.73M | 0.22% | 116 |
|
|
2022
Q3 | $49.4M | Buy |
649,700
+348,500
| +116% | +$28.9M | 0.2% | 133 |
|
|
2022
Q2 | $25.5M | Buy |
+301,200
| New | +$26.4M | 0.11% | 257 |
|
|
2022
Q1 | – | Sell |
-152,900
| Closed | -$13.4M | – | 1321 |
|
|
2021
Q4 | $13.4M | Buy |
+152,900
| New | +$12.7M | 0.05% | 434 |
|
|
2020
Q4 | – | Sell |
-794,930
| Closed | -$69.1M | – | 1069 |
|
|
2020
Q3 | $69.1M | Buy |
+794,930
| New | +$68.9M | 0.35% | 61 |
|
|
2019
Q4 | – | Sell |
-541,255
| Closed | -$47M | – | 1160 |
|
|
2019
Q3 | $47M | Buy |
541,255
+274,355
| +103% | +$24.6M | 0.29% | 100 |
|
|
2019
Q2 | $24.4M | Sell |
266,900
-1,330,874
| -83% | -$113M | 0.13% | 208 |
|
|
2019
Q1 | $138M | Sell |
1,597,774
-133,221
| -8% | -$10.7M | 0.62% | 27 |
|
|
2018
Q4 | $133M | Buy |
1,730,995
+594,608
| +52% | +$46.3M | 0.65% | 28 |
|
|
2018
Q3 | $87.7M | Buy |
+1,136,387
| New | +$84M | 0.36% | 68 |
|
|
2018
Q2 | – | Sell |
-517,585
| Closed | -$37.5M | – | 1125 |
|
|
2018
Q1 | $37.5M | Buy |
517,585
+444,832
| +611% | +$33.9M | 0.16% | 173 |
|
|
2017
Q4 | $5.47M | Buy |
+72,753
| New | +$5.49M | 0.02% | 574 |
|
|
2017
Q3 | – | Sell |
-129,344
| Closed | -$9.67M | – | 1002 |
|
|
2017
Q2 | $9.67M | Sell |
129,344
-619,046
| -83% | -$43.9M | 0.05% | 391 |
|
|
2017
Q1 | $49.8M | Buy |
+748,390
| New | +$49.9M | 0.28% | 89 |
|
|
2014
Q4 | – | Sell |
-23,882
| Closed | -$2.01M | – | 763 |
|
|
2014
Q3 | $2.01M | Sell |
23,882
-53,680
| -69% | -$4.34M | 0.02% | 488 |
|
|
2014
Q2 | $6.29M | Buy |
+77,562
| New | +$6.1M | 0.04% | 415 |
|
Other funds holding NVS
Steven Cohen's NVS Position: Q2 2026 in Review
Steven Cohen reduced its Novartis (NVS) stake by 63% in Q2 2026, selling an estimated $26.6M and leaving 106,157 shares worth $16.6M. The position accounts for 0.02% of the portfolio, ranked #986.
Steven Cohen first reported a position in NVS in Q2 2014 and has held it in 23 quarters since. The position peaked at $167M in Q1 2023. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Steven Cohen held 106,157 shares of Novartis worth $16.6M as of Q2 2026.
- Steven Cohen sold 177,680 Novartis shares in Q2 2026, an estimated $26.6M.
- Novartis made up 0.02% of Steven Cohen's portfolio in Q2 2026, its #986 holding.
- Steven Cohen first reported a position in Novartis in Q2 2014 and has held it in 23 quarters since.
- Steven Cohen's Novartis position peaked at $167M in Q1 2023.
- 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.